Auxilium, Endo, GSK Reach Potential Settlement Of Testosterone MDL Cases
CHICAGO — Testosterone replacement therapy drug makers Auxilium Pharmaceuticals LLC, Endo Pharmaceuticals Inc. and GlaxoSmithKline LLC (GSK) have entered into a potential global settlement, according to a Feb. 23 order by...To view the full article, register now.
Already a subscriber? Click here to view full article